Just before turning the page to 2026, it’s worth pausing to reflect on both the progress made and the challenges that remain in the fight against antimicrobial resistance (AMR). The numbers, unfortunately, haven’t changed. According [...]
More news
From bone flutes to synths, music has always been more than noise — it’s how [...]
The INCATE Selection Committee has chosen four new ventures for Stage I support. Meet the [...]
Did you know phages helped stop a cholera outbreak in Stalingrad during WWII? While antibiotics [...]
In 2025, it is possible — and increasingly common — to treat cancer but lose [...]
At INCATE, we are committed to providing support to early-stage innovators working on antimicrobial resistance [...]
On February 7, 2025, Swiss biopharmaceutical innovator BioVersys made its debut on the SIX Swiss [...]
On the evening of April 9, 2025, The Voltahalle in Basel was the stage of [...]
AdjuTec Pharma AS - 3rd place winner of the Poster Competition at the 9th AMR [...]
